Skip to main content
Year archive

Zealand Pharma — 2018 filings

All 72 regulatory filings released by Zealand Pharma (ZEAL) in 2018, sourced directly from the official regulator.

72 Filings
2018 Period
2018 filings (72)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-12-28 English
Total number of shares and voting rights in Zealand Pharma at December 31, 2018
Share Issue/Capital Change
2018-12-28 English
Share Issue/Capital Change 2018
Share Issue/Capital Change
2018-12-14 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2018-12-14 English
Report Publication Announcement 2018
Report Publication Announcement
2018-12-10 English
Financial calendar for Zealand Pharma in 2019
Report Publication Announcement
2018-12-10 English
Director's Dealing 2018
Director's Dealing
2018-11-28 English
Board/Management Information 2018
Board/Management Information
2018-11-26 English
Zealand Pharma announces change in Executive Management
Board/Management Information
2018-11-26 English
Director's Dealing 2018
Director's Dealing
2018-11-19 English
Director's Dealing 2018
Director's Dealing
2018-11-19 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-11-19 English
Director's Dealing 2018
Director's Dealing
2018-11-19 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-15 English
Zealand Pharma - Interim report for the first nine months of 2018
Interim / Quarterly Report 9M 2018
2018-11-15 English
Zealand grants new warrants under employee warrant program
Share Issue/Capital Change
2018-10-15 English
Zealand grants new warrants under employee warrant program
Share Issue/Capital Change
2018-10-15 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-09-28 English
Total number of shares and voting rights in Zealand Pharma at September 28, 2018
Share Issue/Capital Change
2018-09-28 English
Regulatory Filings 2018
Regulatory Filings
2018-09-27 English
Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Regulatory Filings
2018-09-27 English
Earnings Release 2018
Earnings Release FY 2018
2018-09-18 English
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2018-09-18 English
Share Issue/Capital Change 2018
Share Issue/Capital Change
2018-09-14 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2018-09-14 English
Capital/Financing Update 2018
Capital/Financing Update
2018-09-06 English
Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
Capital/Financing Update
2018-09-06 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-16 English
Zealand Pharma - Interim report for the first half of 2018
Interim / Quarterly Report H1 2018
2018-08-16 English
Earnings Release 2018
Earnings Release Q2 2018
2018-07-31 English
Zealand announces an 85% increase in Soliqua® 100/33/ Suliqua® royalty revenue from first to second quarter of 2018
Earnings Release Q2 2018
2018-07-31 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-07-11 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2018-07-11 English
Share Issue/Capital Change 2018
Share Issue/Capital Change
2018-05-31 English
Zealand announces amendments to its Articles of Association following the granting of warrants
Report Publication Announcement
2018-05-31 English
Regulatory Filings 2018
Regulatory Filings
2018-05-28 English
Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
Regulatory Filings
2018-05-28 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-05-22 English
Director's Dealing 2018
Director's Dealing
2018-05-22 English
Zealand grants new warrants under employee warrant program
Share Issue/Capital Change
2018-05-22 English
Zealand grants new warrants under employee warrant program
Share Issue/Capital Change
2018-05-22 English
Director's Dealing 2018
Director's Dealing
2018-05-22 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-16 English
Zealand Pharma - Interim report for the first quarter of 2018
Interim / Quarterly Report Q1 2018
2018-05-16 English
Earnings Release 2018
Earnings Release Q1 2018
2018-04-27 English
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
Regulatory Filings
2018-04-27 English
Regulatory Filings 2018
Regulatory Filings
2018-04-26 English
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
Regulatory Filings
2018-04-26 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-03-23 English
Director's Dealing 2018
Director's Dealing
2018-03-23 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-03-21 English
Director's Dealing 2018
Director's Dealing
2018-03-21 English
Regulatory Filings 2018
Regulatory Filings
2018-03-20 English
Zealand Pharma's first Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia successfully meets its primary objective
Regulatory Filings
2018-03-20 English
Director's Dealing 2018
Director's Dealing
2018-03-08 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2018-03-08 English
Earnings Release 2017
Earnings Release FY 2017
2018-03-07 English
Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio
Report Publication Announcement
2018-03-07 English
Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio
Annual Report FY 2017
2018-03-07 English
Earnings Release 2017
Earnings Release Q4 2017
2018-02-07 English
Zealand reports royalty revenue for the fourth quarter of 2017
Earnings Release Q4 2017
2018-02-07 English
Regulatory Filings 2018
Regulatory Filings
2018-01-23 English
Zealand Pharma to present Phase 2 results on glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S.
Regulatory Filings
2018-01-23 English
Regulatory Filings 2018
Regulatory Filings
2018-01-23 English
New clinical evidence support potential for glepaglutide as a once-weekly drug for short bowel syndrome (SBS)
Regulatory Filings
2018-01-23 English
Regulatory Filings 2018
Regulatory Filings
2018-01-19 English
Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
Regulatory Filings
2018-01-19 English